Increasing Diversity in Clinical Trials: Overcoming Critical Barriers

Luther T. Clark, Laurence Watkins, Ileana L. Pina, Mary Elmer, Ola Akinboboye, Millicent Gorham, Brenda Jamerson, Cassandra McCullough, Christine Pierre, Adam B. Polis, Gary Puckrein, Jeanne M. Regnante

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex, age, race, ethnicity, lifestyle, and genetic background. Racial and ethnic minorities continue to be underrepresented in cardiovascular and other clinical trials. Although barriers to diversity in trials are well recognized, sustainable solutions for overcoming them have proved elusive. We investigated barriers impacting minority patients’ willingness to participate in trials and—based on literature review and evaluation, and input from key stakeholders, including minority patients, referring physicians, investigators who were minority-serving physicians, and trial coordinators—formulated potential solutions and tested them across stakeholder groups. We identified key themes from solutions that resonated with stakeholders using a transtheoretical model of behavior change and created a communications message map to support a multistakeholder approach for overcoming critical participant barriers.

Original languageEnglish (US)
Pages (from-to)148-172
Number of pages25
JournalCurrent Problems in Cardiology
Volume44
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Clinical Trials
Physicians
Safety
Intrinsic Factor
Life Style
Communication
Research Personnel
Population
Genetic Background

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clark, L. T., Watkins, L., Pina, I. L., Elmer, M., Akinboboye, O., Gorham, M., ... Regnante, J. M. (2019). Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Current Problems in Cardiology, 44(5), 148-172. https://doi.org/10.1016/j.cpcardiol.2018.11.002

Increasing Diversity in Clinical Trials : Overcoming Critical Barriers. / Clark, Luther T.; Watkins, Laurence; Pina, Ileana L.; Elmer, Mary; Akinboboye, Ola; Gorham, Millicent; Jamerson, Brenda; McCullough, Cassandra; Pierre, Christine; Polis, Adam B.; Puckrein, Gary; Regnante, Jeanne M.

In: Current Problems in Cardiology, Vol. 44, No. 5, 01.05.2019, p. 148-172.

Research output: Contribution to journalReview article

Clark, LT, Watkins, L, Pina, IL, Elmer, M, Akinboboye, O, Gorham, M, Jamerson, B, McCullough, C, Pierre, C, Polis, AB, Puckrein, G & Regnante, JM 2019, 'Increasing Diversity in Clinical Trials: Overcoming Critical Barriers', Current Problems in Cardiology, vol. 44, no. 5, pp. 148-172. https://doi.org/10.1016/j.cpcardiol.2018.11.002
Clark LT, Watkins L, Pina IL, Elmer M, Akinboboye O, Gorham M et al. Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Current Problems in Cardiology. 2019 May 1;44(5):148-172. https://doi.org/10.1016/j.cpcardiol.2018.11.002
Clark, Luther T. ; Watkins, Laurence ; Pina, Ileana L. ; Elmer, Mary ; Akinboboye, Ola ; Gorham, Millicent ; Jamerson, Brenda ; McCullough, Cassandra ; Pierre, Christine ; Polis, Adam B. ; Puckrein, Gary ; Regnante, Jeanne M. / Increasing Diversity in Clinical Trials : Overcoming Critical Barriers. In: Current Problems in Cardiology. 2019 ; Vol. 44, No. 5. pp. 148-172.
@article{17df4177a7c44543860aeb3be0e24448,
title = "Increasing Diversity in Clinical Trials: Overcoming Critical Barriers",
abstract = "Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex, age, race, ethnicity, lifestyle, and genetic background. Racial and ethnic minorities continue to be underrepresented in cardiovascular and other clinical trials. Although barriers to diversity in trials are well recognized, sustainable solutions for overcoming them have proved elusive. We investigated barriers impacting minority patients’ willingness to participate in trials and—based on literature review and evaluation, and input from key stakeholders, including minority patients, referring physicians, investigators who were minority-serving physicians, and trial coordinators—formulated potential solutions and tested them across stakeholder groups. We identified key themes from solutions that resonated with stakeholders using a transtheoretical model of behavior change and created a communications message map to support a multistakeholder approach for overcoming critical participant barriers.",
author = "Clark, {Luther T.} and Laurence Watkins and Pina, {Ileana L.} and Mary Elmer and Ola Akinboboye and Millicent Gorham and Brenda Jamerson and Cassandra McCullough and Christine Pierre and Polis, {Adam B.} and Gary Puckrein and Regnante, {Jeanne M.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.cpcardiol.2018.11.002",
language = "English (US)",
volume = "44",
pages = "148--172",
journal = "Current Problems in Cardiology",
issn = "0146-2806",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Increasing Diversity in Clinical Trials

T2 - Overcoming Critical Barriers

AU - Clark, Luther T.

AU - Watkins, Laurence

AU - Pina, Ileana L.

AU - Elmer, Mary

AU - Akinboboye, Ola

AU - Gorham, Millicent

AU - Jamerson, Brenda

AU - McCullough, Cassandra

AU - Pierre, Christine

AU - Polis, Adam B.

AU - Puckrein, Gary

AU - Regnante, Jeanne M.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex, age, race, ethnicity, lifestyle, and genetic background. Racial and ethnic minorities continue to be underrepresented in cardiovascular and other clinical trials. Although barriers to diversity in trials are well recognized, sustainable solutions for overcoming them have proved elusive. We investigated barriers impacting minority patients’ willingness to participate in trials and—based on literature review and evaluation, and input from key stakeholders, including minority patients, referring physicians, investigators who were minority-serving physicians, and trial coordinators—formulated potential solutions and tested them across stakeholder groups. We identified key themes from solutions that resonated with stakeholders using a transtheoretical model of behavior change and created a communications message map to support a multistakeholder approach for overcoming critical participant barriers.

AB - Clinical trial results provide the critical evidence base for evaluating the safety and efficacy of new medicines and medical products. Efficacy and safety may differ among population subgroups depending on intrinsic/extrinsic factors, including sex, age, race, ethnicity, lifestyle, and genetic background. Racial and ethnic minorities continue to be underrepresented in cardiovascular and other clinical trials. Although barriers to diversity in trials are well recognized, sustainable solutions for overcoming them have proved elusive. We investigated barriers impacting minority patients’ willingness to participate in trials and—based on literature review and evaluation, and input from key stakeholders, including minority patients, referring physicians, investigators who were minority-serving physicians, and trial coordinators—formulated potential solutions and tested them across stakeholder groups. We identified key themes from solutions that resonated with stakeholders using a transtheoretical model of behavior change and created a communications message map to support a multistakeholder approach for overcoming critical participant barriers.

UR - http://www.scopus.com/inward/record.url?scp=85057968872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057968872&partnerID=8YFLogxK

U2 - 10.1016/j.cpcardiol.2018.11.002

DO - 10.1016/j.cpcardiol.2018.11.002

M3 - Review article

C2 - 30545650

AN - SCOPUS:85057968872

VL - 44

SP - 148

EP - 172

JO - Current Problems in Cardiology

JF - Current Problems in Cardiology

SN - 0146-2806

IS - 5

ER -